loading
Schlusskurs vom Vortag:
$9.78
Offen:
$9.72
24-Stunden-Volumen:
6,268
Relative Volume:
0.06
Marktkapitalisierung:
$142.31M
Einnahmen:
$166.88M
Nettoeinkommen (Verlust:
$-74.18M
KGV:
-1.9467
EPS:
-5.07
Netto-Cashflow:
$1.14M
1W Leistung:
-1.25%
1M Leistung:
+5.16%
6M Leistung:
-31.97%
1J Leistung:
-42.23%
1-Tages-Spanne:
Value
$9.72
$9.88
1-Wochen-Bereich:
Value
$9.585
$10.17
52-Wochen-Spanne:
Value
$7.8701
$18.37

Anika Therapeutics Inc Stock (ANIK) Company Profile

Name
Firmenname
Anika Therapeutics Inc
Name
Telefon
(781) 457-9000
Name
Adresse
32 WIGGINS AVENUE, BEDFORD, MA
Name
Mitarbeiter
288
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-12
Name
Neueste SEC-Einreichungen
Name
ANIK's Discussions on Twitter

Vergleichen Sie ANIK mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
ANIK
Anika Therapeutics Inc
9.87 141.01M 166.88M -74.18M 1.14M -5.07
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
142.84 63.86B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.41 41.80B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.2433 40.88B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.09 22.98B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
447.64 19.53B 3.08B 1.24B 1.07B 25.61

Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-17 Eingeleitet B. Riley Securities Buy
2024-11-01 Bestätigt Barrington Research Outperform
2023-08-14 Hochstufung Barrington Research Mkt Perform → Outperform
2023-03-07 Herabstufung Barrington Research Outperform → Mkt Perform
2022-11-09 Hochstufung Barrington Research Mkt Perform → Outperform
2022-10-14 Fortgesetzt Stephens Equal-Weight
2022-03-09 Herabstufung Barrington Research Outperform → Mkt Perform
2022-03-09 Herabstufung Stephens Overweight → Equal-Weight
2021-11-16 Eingeleitet Stephens Overweight
2021-07-16 Eingeleitet UBS Neutral
2020-12-16 Hochstufung Barrington Research Mkt Perform → Outperform
2020-05-08 Herabstufung Barrington Research Outperform → Mkt Perform
2020-01-21 Hochstufung Sidoti Neutral → Buy
2020-01-10 Hochstufung First Analysis Sec Outperform → Strong Buy
2019-11-05 Eingeleitet BWS Financial Sell
2019-09-24 Bestätigt Barrington Research Outperform
2019-09-23 Herabstufung First Analysis Sec Strong Buy → Outperform
2019-07-25 Hochstufung First Analysis Sec Neutral → Strong Buy
2019-02-22 Herabstufung First Analysis Sec Outperform → Neutral
2019-02-22 Herabstufung Sidoti Buy → Neutral
2018-07-27 Hochstufung Barrington Research Mkt Perform → Outperform
2018-06-20 Herabstufung Barrington Research Outperform → Mkt Perform
2018-06-20 Herabstufung First Analysis Sec Overweight → Equal-Weight
2018-05-04 Hochstufung Barrington Research Mkt Perform → Outperform
2018-02-23 Herabstufung Barrington Research Outperform → Mkt Perform
2018-01-24 Hochstufung First Analysis Sec Equal-Weight → Overweight
2017-10-27 Bestätigt Barrington Research Outperform
2016-05-09 Hochstufung Singular Research BUY - Long-Term → Buy
2016-04-27 Herabstufung Northland Capital Outperform → Market Perform
2016-02-26 Bestätigt Barrington Research Outperform
Alle ansehen

Anika Therapeutics Inc Aktie (ANIK) Neueste Nachrichten

pulisher
07:06 AM

What is the fair value estimate for Anika Therapeutics Inc. (AKP) stock in 20252025 EndofYear Setup & Technical Pattern Based Signals - newser.com

07:06 AM
pulisher
06:32 AM

What dividend safety rating applies to Anika Therapeutics Inc. (AKP) stockTrade Ideas & Scalable Portfolio Growth Methods - newser.com

06:32 AM
pulisher
05:28 AM

Is Anika Therapeutics Inc. stock supported by strong cash flows2025 Winners & Losers & Weekly Setup with High ROI Potential - newser.com

05:28 AM
pulisher
04:41 AM

Why Anika Therapeutics Inc. stock could rally in 2025Weekly Profit Analysis & Breakout Confirmation Alerts - newser.com

04:41 AM
pulisher
02:57 AM

Does Anika Therapeutics Inc. show high probability of reboundJuly 2025 EndofMonth & Safe Entry Trade Reports - newser.com

02:57 AM
pulisher
01:25 AM

Detecting support and resistance levels for Anika Therapeutics Inc.Sell Signal & Safe Entry Point Identification - newser.com

01:25 AM
pulisher
Oct 30, 2025

Is Anika Therapeutics Inc. stock positioned for long term growthTrade Ideas & Risk Managed Investment Entry Signals - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Strategies to average down on Anika Therapeutics Inc.2025 Year in Review & Free High Accuracy Swing Entry Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Key metrics from Anika Therapeutics Inc.’s quarterly data2025 Retail Activity & Low Risk Entry Point Tips - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Why Anika Therapeutics Inc. stock could outperform in 20252025 Support & Resistance & Free Fast Gain Swing Trade Alerts - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

How to escape a deep drawdown in Anika Therapeutics Inc.2025 Growth vs Value & Smart Allocation Stock Reports - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Anika Therapeutics, Inc. (NASDAQ:ANIK) is a favorite amongst institutional investors who own 60% - Yahoo Finance

Oct 28, 2025
pulisher
Oct 28, 2025

Using AI based signals to follow Anika Therapeutics Inc.Quarterly Investment Review & Stepwise Entry/Exit Trade Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Can Anika Therapeutics Inc. stock sustain revenue growth2025 Momentum Check & Real-Time Price Movement Reports - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 27, 2025

Will Anika Therapeutics Inc. (AKP) stock benefit from sector leadershipMarket Performance Report & Daily Technical Forecast Reports - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Can Anika Therapeutics Inc. stock attract ESG capital inflowsJuly 2025 Macro Moves & Fast Gain Swing Alerts - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Is Anika Therapeutics Inc. stock attractive for growth ETFsWeekly Gains Summary & Long-Term Safe Investment Ideas - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Anika Therapeutics’ Integrity Implant System Study: A Market Game Changer? - TipRanks

Oct 27, 2025

Finanzdaten der Anika Therapeutics Inc-Aktie (ANIK)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Anika Therapeutics Inc-Aktie (ANIK) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Nunes Anne
SVP, Chief Operations Officer
Mar 17 '25
Option Exercise
0.00
3,637
0
21,722
Colleran David
EVP, General Counsel, Corp Sec
Mar 17 '25
Option Exercise
0.00
6,448
0
49,847
Blanchard Cheryl R
President, CEO, Director
Mar 17 '25
Option Exercise
0.00
25,132
0
209,472
Nunes Anne
SVP, Chief Operations Officer
Mar 11 '25
Option Exercise
0.00
2,561
0
18,837
Colleran David
EVP, General Counsel, Corp Sec
Mar 11 '25
Option Exercise
0.00
7,663
0
45,649
Blanchard Cheryl R
President, CEO, Director
Mar 11 '25
Option Exercise
0.00
30,060
0
197,015
Nunes Anne
SVP, Chief Operations Officer
Mar 10 '25
Option Exercise
0.00
3,296
0
17,235
Colleran David
EVP, General Counsel, Corp Sec
Mar 10 '25
Option Exercise
0.00
5,465
0
39,590
Blanchard Cheryl R
President, CEO, Director
Mar 10 '25
Option Exercise
0.00
20,002
0
172,826
$46.91
price up icon 6.10%
drug_manufacturers_specialty_generic RDY
$13.31
price down icon 1.04%
$22.70
price up icon 0.55%
$10.39
price up icon 0.25%
$140.50
price up icon 1.73%
$448.78
price down icon 1.16%
Kapitalisierung:     |  Volumen (24h):